The present invention provides, inter alia, a process for producing a compound of Formula (I): wherein A.sup.1, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as defined herein. The present invention further provides intermediate compounds utilised in said process, and methods for producing said intermediate compounds.

##STR00001##

The present invention provides, inter alia, a process for producing a compound of Formula (I): wherein A.sup.1, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as defined herein. The present invention further provides intermediate compounds utilised in said process, and methods for producing said intermediate compounds.

##STR00001##

Provided is a silver ink including, as a major component, a silver malonate precursor represented by Formula 1 or Formula 2.

Provided is a silver ink including, as a major component, a silver malonate precursor represented by Formula 1 or Formula 2.

The present disclosure relates generally to organic compounds. More specifically, the disclosure is directed to a dihydrazide-dihydrazone compound of Formula (I), a stereoisomer, a tautomer, a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof. The compounds of the present disclosure possess anti-microbial activity, specifically antifungal and antibacterial activity. The present disclosure also provides a process of synthesis of the compound of Formula (I).

##STR00001##